AIMS/HYPOTHESIS: Studying gene-lifestyle interaction may help to identify lifestyle factors that modify genetic susceptibility and uncover genetic loci exerting important subgroup effects. Adequately powered studies with prospective, unbiased, standardised assessment of key behavioural factors for gene-lifestyle studies are lacking. This case-cohort study aims to investigate how genetic and potentially modifiable lifestyle and behavioural factors, particularly diet and physical activity, interact in their influence on the risk of developing type 2 diabetes. METHODS: Incident cases of type 2 diabetes occurring in European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts between 1991 and 2007 from eight of the ten EPIC countries were ascertained and verified. Prentice-weighted Cox regression and random-effects meta-analyses were used to investigate differences in diabetes incidence by age and sex. RESULTS: A total of 12,403 verified incident cases of type 2 diabetes occurred during 3.99 million person-years of follow-up of 340,234 EPIC participants eligible for InterAct. We defined a centre-stratified subcohort of 16,154 individuals for comparative analyses. Individuals with incident diabetes who were randomly selected into the subcohort (n = 778) were included as cases in the analyses. All prevalent diabetes cases were excluded from the study. InterAct cases were followed-up for an average of 6.9 years; 49.7% were men. Mean baseline age and age at diagnosis were 55.6 and 62.5 years, mean BMI and waist circumference values were 29.4 kg/m(2) and 102.7 cm in men, and 30.1 kg/m(2) and 92.8 cm in women, respectively. Risk of type 2 diabetes increased linearly with age, with an overall HR of 1.56 (95% CI 1.48-1.64) for a 10 year age difference, adjusted for sex. A male excess in the risk of incident diabetes was consistently observed across all countries, with a pooled HR of 1.51 (95% CI 1.39-1.64), adjusted for age. CONCLUSIONS/ INTERPRETATION: InterAct is a large, well-powered, prospective study that will inform our understanding of the interplay between genes and lifestyle factors on the risk of type 2 diabetes development.
AIMS/HYPOTHESIS: Studying gene-lifestyle interaction may help to identify lifestyle factors that modify genetic susceptibility and uncover genetic loci exerting important subgroup effects. Adequately powered studies with prospective, unbiased, standardised assessment of key behavioural factors for gene-lifestyle studies are lacking. This case-cohort study aims to investigate how genetic and potentially modifiable lifestyle and behavioural factors, particularly diet and physical activity, interact in their influence on the risk of developing type 2 diabetes. METHODS: Incident cases of type 2 diabetes occurring in European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts between 1991 and 2007 from eight of the ten EPIC countries were ascertained and verified. Prentice-weighted Cox regression and random-effects meta-analyses were used to investigate differences in diabetes incidence by age and sex. RESULTS: A total of 12,403 verified incident cases of type 2 diabetes occurred during 3.99 million person-years of follow-up of 340,234 EPIC participants eligible for InterAct. We defined a centre-stratified subcohort of 16,154 individuals for comparative analyses. Individuals with incident diabetes who were randomly selected into the subcohort (n = 778) were included as cases in the analyses. All prevalent diabetes cases were excluded from the study. InterAct cases were followed-up for an average of 6.9 years; 49.7% were men. Mean baseline age and age at diagnosis were 55.6 and 62.5 years, mean BMI and waist circumference values were 29.4 kg/m(2) and 102.7 cm in men, and 30.1 kg/m(2) and 92.8 cm in women, respectively. Risk of type 2 diabetes increased linearly with age, with an overall HR of 1.56 (95% CI 1.48-1.64) for a 10 year age difference, adjusted for sex. A male excess in the risk of incident diabetes was consistently observed across all countries, with a pooled HR of 1.51 (95% CI 1.39-1.64), adjusted for age. CONCLUSIONS/ INTERPRETATION: InterAct is a large, well-powered, prospective study that will inform our understanding of the interplay between genes and lifestyle factors on the risk of type 2 diabetes development.
Authors: N Slimani; G Deharveng; R U Charrondière; A L van Kappel; M C Ocké; A Welch; A Lagiou; M van Liere; A Agudo; V Pala; B Brandstetter; C Andren; C Stripp; W A van Staveren; E Riboli Journal: Comput Methods Programs Biomed Date: 1999-03 Impact factor: 5.428
Authors: Sergio Valdés; Patricia Botas; Elias Delgado; Francisco Alvarez; Francisco Diaz Cadórniga Journal: Diabetes Care Date: 2007-05-29 Impact factor: 19.112
Authors: Jose C Florez; Kathleen A Jablonski; Nick Bayley; Toni I Pollin; Paul I W de Bakker; Alan R Shuldiner; William C Knowler; David M Nathan; David Altshuler Journal: N Engl J Med Date: 2006-07-20 Impact factor: 91.245
Authors: Søren Brage; Ulf Ekelund; Niels Brage; Mark A Hennings; Karsten Froberg; Paul W Franks; Nicholas J Wareham Journal: J Appl Physiol (1985) Date: 2007-04-26
Authors: Nicholas J Timpson; Cecilia M Lindgren; Michael N Weedon; Joshua Randall; Willem H Ouwehand; David P Strachan; N William Rayner; Mark Walker; Graham A Hitman; Alex S F Doney; Colin N A Palmer; Andrew D Morris; Andrew T Hattersley; Eleftheria Zeggini; Timothy M Frayling; Mark I McCarthy Journal: Diabetes Date: 2008-12-03 Impact factor: 9.461
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: D Romaguera; T Norat; P A Wark; A C Vergnaud; M B Schulze; G J van Woudenbergh; D Drogan; P Amiano; E Molina-Montes; M J Sánchez; B Balkau; A Barricarte; J W J Beulens; F Clavel-Chapelon; S P Crispim; G Fagherazzi; P W Franks; V A Grote; I Huybrechts; R Kaaks; T J Key; K T Khaw; P Nilsson; K Overvad; D Palli; S Panico; J R Quirós; O Rolandsson; C Sacerdote; S Sieri; N Slimani; A M W Spijkerman; A Tjonneland; M J Tormo; R Tumino; S W van den Berg; P R Wermeling; R Zamara-Ros; E J M Feskens; C Langenberg; S J Sharp; N G Forouhi; E Riboli; N J Wareham Journal: Diabetologia Date: 2013-04-26 Impact factor: 10.122
Authors: Franziska Jannasch; Janine Kröger; Claudia Agnoli; Aurelio Barricarte; Heiner Boeing; Valerie Cayssials; Sandra Colorado-Yohar; Christina C Dahm; Courtney Dow; Guy Fagherazzi; Paul W Franks; Heinz Freisling; Marc J Gunter; Nicola D Kerrison; Timothy J Key; Kay-Tee Khaw; Tilman Kühn; Cecilie Kyro; Francesca Romana Mancini; Olatz Mokoroa; Peter Nilsson; Kim Overvad; Domenico Palli; Salvatore Panico; Jose Ramón Quirós García; Olov Rolandsson; Carlotta Sacerdote; Mariá-José Sánchez; Mohammad Sediq Sahrai; Ruth Schübel; Ivonne Sluijs; Annemieke M W Spijkerman; Anne Tjonneland; Tammy Y N Tong; Rosario Tumino; Elio Riboli; Claudia Langenberg; Stephen J Sharp; Nita G Forouhi; Matthias B Schulze; Nicholas J Wareham Journal: J Nutr Date: 2019-06-01 Impact factor: 4.798